OncoVista Innovative Therapies (OncoVista Innovative Therapies) Market Cap : $0.00 Mil (As of May. 25, 2024)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OncoVista Innovative Therapies's share price for the quarter that ended in Sep. 2015 was $0.42. OncoVista Innovative Therapies's Shares Outstanding (EOP) for the quarter that ended in Sep. 2015 was 23.56 Mil. Therefore, OncoVista Innovative Therapies's market cap for the quarter that ended in Sep. 2015 was $9.89 Mil.

OncoVista Innovative Therapies's quarterly market cap increased from Mar. 2015 ($9.91 Mil) to Jun. 2015 ($20.25 Mil) but then declined from Jun. 2015 ($20.25 Mil) to Sep. 2015 ($9.89 Mil).

OncoVista Innovative Therapies's annual market cap declined from Dec. 2012 ($2.81 Mil) to Dec. 2013 ($1.08 Mil) but then increased from Dec. 2013 ($1.08 Mil) to Dec. 2014 ($1.32 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OncoVista Innovative Therapies's Enterprise Value for Today is $0.00 Mil.

OncoVista Innovative Therapies Market Cap Historical Data

The historical data trend for OncoVista Innovative Therapies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Market Cap Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Market Cap

Get a 7-Day Free Trial

6.98

7.48

2.81

1.08

1.32

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Market Cap	Get a 7-Day Free Trial															5.19	1.32	9.91	20.25	9.89

Competitive Comparison of OncoVista Innovative Therapies's Market Cap

For the Biotechnology subindustry, OncoVista Innovative Therapies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Market Cap distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Market Cap falls into.

OncoVista Innovative Therapies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

OncoVista Innovative Therapies's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as

Market Cap (A: Dec. 2014 )	=	Share Price (A: Dec. 2014 )	*	Shares Outstanding (EOP) (A: Dec. 2014 )
	=	$0.06	*	22.0129
	=	$1.32

OncoVista Innovative Therapies's Market Cap for the quarter that ended in Sep. 2015 is calculated as

Market Cap (Q: Sep. 2015 )	=	Share Price (Q: Sep. 2015 )	*	Shares Outstanding (EOP) (Q: Sep. 2015 )
	=	$0.42	*	23.5585
	=	$9.89

OncoVista Innovative Therapies (OTCPK:OVIT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

OncoVista Innovative Therapies Market Cap Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines